Uncovering Potential: NRX Pharmaceuticals's Earnings Preview
NRX Pharmaceuticals (NRXP) is set to release its quarterly earnings report on May 15, 2025, with analysts predicting an earnings per share (EPS) of $-0.40. Investors are hopeful for positive guidance despite a 37.22% decline in share price over the past year, trading at $2.29 as of May 13. The upcoming announcement is crucial as stock prices may be influenced more by future projections than past performance.
NRX Pharmaceuticals NRXP will release its quarterly earnings report on Thursday, 2025-05-15. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate NRX Pharmaceuticals to report an earnings per share (EPS) of $-0.40.
Investors in NRX Pharmaceuticals are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Here's a look at NRX Pharmaceuticals's past performance and the resulting price change:
Performance of NRX Pharmaceuticals Shares
Shares of NRX Pharmaceuticals were trading at $2.29 as of May 13. Over the last 52-week period, shares are down 37.22%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for NRX Pharmaceuticals visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
